Cargando…

Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy

In a clinical case series, 5 patients with not-resolved central serous choroidoretinopathy (CSC) lasting more than 1 year received one intravitreal bevacizumab injection (IVB, 1.25 mg) injection. All patients underwent a through ophthalmic examination 1 day, 1 week, and 1, 2, and 6 months after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Entezari, Morteza, Ramezani, Alireza, Yaseri, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325620/
https://www.ncbi.nlm.nih.gov/pubmed/22511842
http://dx.doi.org/10.3341/kjo.2012.26.2.139